Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Academic Screening Workshop

Academic Screening Workshop Agenda




Thursday, 20 September 2012

08:30

Emory Chemical Biology Discovery Centre
Haian Fu, Professor and Director, Emory University, United States of America

09:00

Medicinal Chemistry Capabilities in Academic Drug Discovery: You have a hit…what's next?
Michael Walters, Director of Combinatorial Chemistry Laboratory, University of Minnesota, United States of America

09:30

The Sloan-Kettering Discovery Engine & Approach
Christophe Antczak, Assistant Director, Memorial Sloan Kettering Cancer Center, United States of America

10:00

High Throughput Flow Cytometry at the University of New Mexico Center for Molecular Discovery: Cellular and Molecular Targets in Multiplexed and Multiparameter Format
Larry Sklar, Director, University of New Mexico Health Sciences Center, United States of America

10:30

Coffee Break and Networking

11:15

Seven years of HTS/HCS at the University of Pittsburgh - it’s the Collaborations Baby
Paul Johnston, Research Associate Professor, University of Pittsburgh, United States of America

12:15

EU-OPENSCREEN, Chemical Keys for Life's Locks
Bahne Stechmann, Scientific Manager, Leibniz-Institut für Molekulare Pharmakologie, Germany

12:45

BARD: BioAssay Research Database
Christopher Austin, Director, National Institutes of Health, United States of America

13:20

Lunch, Poster Viewing and Networking

14:30

Expert Panel discussion on “Trends on enabling technologies & the future of academic screening”
John Watson, Director, Promega Corporation, United States of America

Panelists: Rathnam Chaguturu, SRI; Terry Riss, Promega; Jim Inglese, NIH; Larry Sklar, University of New Mexico; Paul Johnson, University of Pittsburg; Haian Fu, Emory; Michael Walters, Minnesota; Edward Hyde, Upenn; Christophe Antczak, MSKCC; Jennifer Smith, HMS; Bahne Stechmann, EU-OPENSCREEN; Donato Tedesco, Cellecta; Blake Anson, Cellular Dynamics International; Tim Cloutier, Perkin Elmer; Pavel Fomitchov, GE Healthcare Life Sciences





18:00

Drinks Reception

Friday, 21 September 2012

08:00

Open Innovation-based Public-Private Partnerships: Promise or Panacea for Precompetitive Drug Discovery Initiatives
Rathnam Chaguturu, Founder and CEO/Senior Director, SRI International, United States of America

08:30

Academic-Industry Partnerships, the Challenges of Advancing and Managing Innovation
Robert Zivin, Research Associate Professor, University of Miami, United States of America

09:00

An Industrial Perspective of HTS in Academia
Ricardo Macarron, Vice President, GlaxoSmithKline, United States of America

09:30

Integrating Target Validation, Drug Discovery and Chemical Biology
John Hayley, Senior Director, EMT, Biology, OSI Pharmaceuticals, United States of America

10:00

The Conrad Prebys Center for Chemical Genomics for Internal and Collaborative Pre-clinical Drug Discovery with Pharma Co/Biotech Partners – Lessons Learned and Best Practices
Thomas Chung, Director of Outreach/Project Manager, Sanford Burnham Medical Research Institute, United States of America

10:30

Coffee Break and Networking

11:15

Pre-Competitive Collaboration at the Structural Genomics Consortium
Peter Brown, Principal Investigator, University of Toronto, Canada

11:45

Promega’s New Outreach Program to Support Design of Assays Submitted to Academic Screening Centers
Terry Riss, Senior Product Manager, Cell Health, Promega Corporation, United States of America

12:15

GVK BIO as an Academic Partner - Value-added, High Quality, Cost-effective Enabler of Drug Discovery & Development
Mohan Thiruvazhi, Director, GVK Bio, India

12:45

Lunch, Poster Viewing and Networking

14:30

Expert panel discussion on “Should academia be doing drug discovery?”
Rathnam Chaguturu, Founder and CEO/Senior Director, SRI International, United States of America

Panelists: Hakim Djaballah, MSKCC; Jim Inglese, NIH; Robert Zivin, Johnson & Johnson; Mel Reichman, LIMR; Ricardo Macarron, GSK; David Epstein, OSI Pharmaceuticals; Mohan Thiruvazhi, GVK Bio; Peter Brown, University of Toronto; Thomas Chung, Burnham; Terry Riss, Promega

17:00

Workshop Ends